1. Home
  2. TLIH vs CVKD Comparison

TLIH vs CVKD Comparison

Compare TLIH & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TLIH

Ten-League International Holdings Limited Ordinary Shares

HOLD

Current Price

$0.41

Market Cap

11.8M

Sector

N/A

ML Signal

HOLD

Logo Cadrenal Therapeutics Inc.

CVKD

Cadrenal Therapeutics Inc.

HOLD

Current Price

$8.12

Market Cap

13.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLIH
CVKD
Founded
1998
2022
Country
Singapore
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
13.3M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
TLIH
CVKD
Price
$0.41
$8.12
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$32.00
AVG Volume (30 Days)
1.8M
48.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.34
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$4.91
52 Week High
$7.00
$20.39

Technical Indicators

Market Signals
Indicator
TLIH
CVKD
Relative Strength Index (RSI) 52.71 62.07
Support Level $0.35 $6.64
Resistance Level $0.52 $8.79
Average True Range (ATR) 0.05 0.64
MACD 0.01 0.40
Stochastic Oscillator 41.02 87.03

Price Performance

Historical Comparison
TLIH
CVKD

About TLIH Ten-League International Holdings Limited Ordinary Shares

Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental and provision of engineering consultancy services to port, construction, civil engineering and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment and port machinery. The company operates in Singapore and Other International Countries.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: